Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment.

Wormser GP, Shapiro ED, Halperin JJ, Porwancher RB, O'Connell S, Nadelman RB, Strle F, Radolf JD, Hovius JW, Baker PJ, Fingerle V, Dattwyler R.

Minerva Med. 2009 Apr;100(2):171-2. No abstract available.

PMID:
19390504
3.

Obstacles to trials of chronic Lyme disease in actual practice.

Cameron D.

Minerva Med. 2009 Oct;100(5):435-6. No abstract available.

PMID:
19910896
4.
5.

Management of Lyme arthritis.

Sigal LH.

Compr Ther. 1999 Apr;25(4):228-38. Review.

PMID:
10349093
6.

Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease.

Klempner MS.

Vector Borne Zoonotic Dis. 2002 Winter;2(4):255-63. Review.

PMID:
12804167
7.
8.
9.

Re: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Prolonged Lyme disease treatment: enough is enough.

Marques A, Shaw P, Schmid CH, Steere A, Kaplan RF, Hassett A, Shapiro E, Wormser GP.

Neurology. 2009 Jan 27;72(4):383-4; author reply 384. doi: 10.1212/01.wnl.0000343855.45704.7c. No abstract available.

PMID:
19171842
10.

Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease.

Stricker RB.

Clin Infect Dis. 2007 Jul 15;45(2):149-57. Epub 2007 Jun 5. Review.

PMID:
17578772
11.

Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials.

Delong AK, Blossom B, Maloney EL, Phillips SE.

Contemp Clin Trials. 2012 Nov;33(6):1132-42. doi: 10.1016/j.cct.2012.08.009. Epub 2012 Aug 19. Review.

PMID:
22922244
12.

Treatment of early Lyme disease.

Stricker RB, Gaito A, Harris NS, Burrascano JJ.

Ann Intern Med. 2004 Apr 6;140(7):577; author reply 577-8. No abstract available.

PMID:
15068989
13.

Treatment of patients with persistent symptoms and a history of Lyme disease.

Bransfield R, Brand S, Sherr V.

N Engl J Med. 2001 Nov 8;345(19):1424-5. No abstract available.

14.

Lyme disease.

DeLong A.

Med Health R I. 2008 Dec;91(12):390; author reply 390. No abstract available.

PMID:
19170319
15.

Sickle cell patients deserve controlled recommendations.

Strauss RG.

Transfusion. 2002 May;42(5):658-9; author reply 659-60. No abstract available.

PMID:
12084176
16.

Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A.

N Engl J Med. 2001 Jul 12;345(2):85-92.

17.

[Treatment and follow up of disseminated and late Lyme disease].

Mohseni Zadeh M.

Med Mal Infect. 2007 Jul-Aug;37(7-8):368-80. Epub 2007 Aug 17. Review. French.

PMID:
17707605
18.

Lyme disease.

Hayes E.

Clin Evid. 2002 Jun;(7):652-64. Review. No abstract available. Update in: Clin Evid. 2002 Dec;(8):721-33.

PMID:
12230693
19.

Lyme disease vaccine.

[No authors listed]

Med Lett Drugs Ther. 1999 Mar 26;41(1049):29-30. No abstract available.

PMID:
10205597

Supplemental Content

Support Center